BIO-key International (NASDAQ:BKYI) Issues Earnings Results, Misses Estimates By $0.18 EPS

BIO-key International (NASDAQ:BKYI) posted its quarterly earnings results on Thursday. The technology company reported ($0.53) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.18), Zacks reports. BIO-key International had a negative return on equity of 3,124.77% and a negative net margin of 72.53%. The business had revenue of $1.46 million during the quarter, compared to the consensus estimate of $2.29 million.

BIO-key International Trading Down 4.9 %

Shares of BKYI stock opened at $0.81 on Friday. The business has a 50-day moving average of $1.20 and a 200 day moving average of $1.15. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.78 and a quick ratio of 0.71. BIO-key International has a 1-year low of $0.52 and a 1-year high of $3.68. The stock has a market capitalization of $2.54 million, a PE ratio of -0.36 and a beta of -0.10.

About BIO-key International

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.